Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Inhalative Doses of BEA 2180 BR in Healthy Male Volunteers

NCT02254122 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

59

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: BEA 2180 BR
DRUG: Placebo
DEVICE: Respimat®

Sponsor

Boehringer Ingelheim